Cyfuse Biomedical K.K. (4892.T)

JPY 463.0

(2.89%)

Revenue Summary of Cyfuse Biomedical K.K.

  • Cyfuse Biomedical K.K.'s latest annual revenue in 2023 was 61.11 Million JPY , down -83.68% from previous year.
  • Cyfuse Biomedical K.K.'s latest quarterly revenue in 2024 Q2 was 7.29 Million JPY , down -32.09% from previous quarter.
  • Cyfuse Biomedical K.K. reported a annual revenue of 374.47 Million JPY in annual revenue 2022, down -47.13% from previous year.
  • Cyfuse Biomedical K.K. reported a annual revenue of 708.24 Million JPY in annual revenue 2021, up 415.15% from previous year.
  • Cyfuse Biomedical K.K. reported a quarterly revenue of 10.74 Million JPY for 2024 Q1, down -65.76% from previous quarter.
  • Cyfuse Biomedical K.K. reported a quarterly revenue of 31.38 Million JPY for 2023 Q4, up 173.92% from previous quarter.

Annual Revenue Chart of Cyfuse Biomedical K.K. (2023 - 2020)

Historical Annual Revenue of Cyfuse Biomedical K.K. (2023 - 2020)

Year Revenue Revenue Growth
2023 61.11 Million JPY -83.68%
2022 374.47 Million JPY -47.13%
2021 708.24 Million JPY 415.15%
2020 137.48 Million JPY 0.0%

Peer Revenue Comparison of Cyfuse Biomedical K.K.

Name Revenue Revenue Difference
Pharma Foods International Co., Ltd. 62.14 Billion JPY 99.902%
Takeda Pharmaceutical Company Limited 4263.76 Billion JPY 99.999%
Sumitomo Pharma Co., Ltd. 314.55 Billion JPY 99.981%
Shionogi & Co., Ltd. 435.08 Billion JPY 99.986%
Wakamoto Pharmaceutical Co.,Ltd. 7.73 Billion JPY 99.21%
Nippon Shinyaku Co., Ltd. 148.25 Billion JPY 99.959%
Kaken Pharmaceutical Co., Ltd. 72.04 Billion JPY 99.915%
Eisai Co., Ltd. 741.75 Billion JPY 99.992%
Morishita Jintan Co., Ltd. 12.4 Billion JPY 99.507%
Hisamitsu Pharmaceutical Co., Inc. 141.7 Billion JPY 99.957%
Mochida Pharmaceutical Co., Ltd. 102.88 Billion JPY 99.941%
Fuso Pharmaceutical Industries,Ltd. 55.4 Billion JPY 99.89%
Nippon Chemiphar Co., Ltd. 30.74 Billion JPY 99.801%
Tsumura & Co. 150.84 Billion JPY 99.959%
Kissei Pharmaceutical Co., Ltd. 75.57 Billion JPY 99.919%
Torii Pharmaceutical Co., Ltd. 54.63 Billion JPY 99.888%
Towa Pharmaceutical Co., Ltd. 227.93 Billion JPY 99.973%
Fuji Pharma Co., Ltd. 40.88 Billion JPY 99.851%
Zeria Pharmaceutical Co., Ltd. 75.72 Billion JPY 99.919%
KYORIN Holdings, Inc. 119.53 Billion JPY 99.949%
Taiko Pharmaceutical Co.,Ltd. 5.04 Billion JPY 98.787%
Daito Pharmaceutical Co.,Ltd. 46.89 Billion JPY 99.87%
SymBio Pharmaceuticals Limited 5.58 Billion JPY 98.907%
MedRx Co., Ltd 26 Million JPY -135.046%
Mizuho Medy Co.,Ltd. 10.98 Billion JPY 99.444%
Solasia Pharma K.K. 617 Million JPY 90.095%
Modalis Therapeutics Corporation - JPY -Infinity%
ASKA Pharmaceutical Holdings Co.,Ltd. 62.84 Billion JPY 99.903%
Sawai Group Holdings Co., Ltd. 176.86 Billion JPY 99.965%
Toho Holdings Co., Ltd. 1476.71 Billion JPY 99.996%
Koa Shoji Holdings Co.,Ltd. 22.13 Billion JPY 99.724%